
Baudax Bio Announces Exercise of Warrants for Gross Proceeds of $13.4 Million
MALVERN, PA — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, recently announced the agreement by an accredited healthcare-focused institutional investor to cash …
Read More